Protokinetix Names Key Addition to Its Executive Management Team

ProtoKinetix Inc.’s (OTCBB:PKTX) Board of Directors is pleased to be able to announce the appointment of Randy Anderson as its Vice President of Government Affairs. Mr. Anderson has been a long term governmental liaison specialist, based in Washington, D.C. Randy will be working very closely with our Washington, D.C. team of business advisors. In this capacity, Mr. Anderson will be directing the development of AAGP™ applications into the United States military and government health care initiatives.

ProtoKinetix, Inc. views this appointment as an integral step towards successful collaboration with key U.S. government agencies. ProtoKinetix’ AAGP™ has demonstrated the ability to dramatically extend the shelf life of blood products and platelets. The strategic and economic importance of this application has been clearly stated by Don Weber, Chairman of Logistics Health, in the March 5th PKTX News Release.

ProtoKinetix’ recently appointed member of its Business Advisory Board, Don Weber, states that “I have known Randy Anderson for over 20-years. I first met him when he was working for a national program created by the White House Office of Private Sector Initiatives under President Ronald Reagan. In 2001, I hired Randy to manage the Anthrax Response Team for postal facilities in Washington, D.C. and Trenton, New Jersey under a contract with the Centers for Disease Control and Prevention (CDC). He is an effective manager who knows his way around Washington.”

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For more detailed information, please visit our website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO

ProtoKinetix Inc.
Investor Contact
Blair Henderson, 604-687-9887